Aripiprazole for late-life schizophrenia
Jeffrey Rado, Philip G JanicakPsychiatric Clinical Research Center, Rush University Medical Center, Chicago, IL, USAAbstract: Antipsychotics are frequently used in elderly patients to treat a variety of conditions, including schizophrenia. While extensively studied for their impact in younger &s...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/82cedea055084d7987558f126be3c376 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:82cedea055084d7987558f126be3c376 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:82cedea055084d7987558f126be3c3762021-12-02T06:20:40ZAripiprazole for late-life schizophrenia1178-1998https://doaj.org/article/82cedea055084d7987558f126be3c3762010-08-01T00:00:00Zhttps://www.dovepress.com/aripiprazole-for-late-life-schizophrenia-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Jeffrey Rado, Philip G JanicakPsychiatric Clinical Research Center, Rush University Medical Center, Chicago, IL, USAAbstract: Antipsychotics are frequently used in elderly patients to treat a variety of conditions, including schizophrenia. While extensively studied for their impact in younger ­populations, there is comparatively limited evidence about the effectiveness of these agents in older patients. Further complicating this situation are the high co-morbidity rates (both psychiatric and ­medical) in the elderly; age-related changes in pharmacokinetics leading to a heightened proclivity for adverse effects; and the potential for multiple, clinically relevant drug interactions. With this background in mind, we review diagnostic and treatment-related issues specific to elderly patients suffering from schizophrenia and other psychotic conditions, focusing on the potential role of aripiprazole.Keywords: aripiprazole, schizophrenia, elderly, dopamine partial antagonistJeffrey RadoPhilip G JanicakDove Medical PressarticleAripiprazoleSchizophreniaelderlyGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 5, Pp 253-258 (2010) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Aripiprazole Schizophrenia elderly Geriatrics RC952-954.6 |
spellingShingle |
Aripiprazole Schizophrenia elderly Geriatrics RC952-954.6 Jeffrey Rado Philip G Janicak Aripiprazole for late-life schizophrenia |
description |
Jeffrey Rado, Philip G JanicakPsychiatric Clinical Research Center, Rush University Medical Center, Chicago, IL, USAAbstract: Antipsychotics are frequently used in elderly patients to treat a variety of conditions, including schizophrenia. While extensively studied for their impact in younger ­populations, there is comparatively limited evidence about the effectiveness of these agents in older patients. Further complicating this situation are the high co-morbidity rates (both psychiatric and ­medical) in the elderly; age-related changes in pharmacokinetics leading to a heightened proclivity for adverse effects; and the potential for multiple, clinically relevant drug interactions. With this background in mind, we review diagnostic and treatment-related issues specific to elderly patients suffering from schizophrenia and other psychotic conditions, focusing on the potential role of aripiprazole.Keywords: aripiprazole, schizophrenia, elderly, dopamine partial antagonist |
format |
article |
author |
Jeffrey Rado Philip G Janicak |
author_facet |
Jeffrey Rado Philip G Janicak |
author_sort |
Jeffrey Rado |
title |
Aripiprazole for late-life schizophrenia |
title_short |
Aripiprazole for late-life schizophrenia |
title_full |
Aripiprazole for late-life schizophrenia |
title_fullStr |
Aripiprazole for late-life schizophrenia |
title_full_unstemmed |
Aripiprazole for late-life schizophrenia |
title_sort |
aripiprazole for late-life schizophrenia |
publisher |
Dove Medical Press |
publishDate |
2010 |
url |
https://doaj.org/article/82cedea055084d7987558f126be3c376 |
work_keys_str_mv |
AT jeffreyrado aripiprazoleforlatelifeschizophrenia AT philipgjanicak aripiprazoleforlatelifeschizophrenia |
_version_ |
1718399944007614464 |